Skip to main content
All lobbying filings

Federal Health Counsel, LLC

Federal Health Counsel, LLC filed a Q1 report for Amgen, Inc. on April 21, 2025.

Lobbying for Amgen, Inc. · Pharmaceutical Company

As filed: FEDERAL HEALTH COUNSEL, LLC for AMGEN, INC.

All filings by Federal Health Counsel, LLC · Everything Amgen, Inc. has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 21, 2025
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
District of Columbia

Official filing document

 Lobbying activity 1

Issues related to the implementation of the Medicare Drug Negotiations and the calculation of the Medicaid rebate and best price.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem